Trial intelligence / Profile preview

Salbutamol vs diphenhydramine to reduce respiratory adverse events during ophthalmologic examination under anesthesia in children with common cold

IRCT20141209020253N1Phase 3Recruiting

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of salbutamol and diphenhydramine in nasopharyngitis and peri-anesthetic respiratory event (PRAE) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Incidence of adverse respiratory events during ophthalmologic examination under anesthesia. Started Jan 2025; status: recruiting.

02

Drugs

salbutamoldiphenhydramine
03

Conditions

nasopharyngitisperi-anesthetic respiratory event (PRAE)

Beyond the preview

Go deeper on IRCT20141209020253N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141209020253N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call